Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Frederiksberg

31 clinical trials in Frederiksberg, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Frederiksberg at a glance
31
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

31 trials in Frederiksberg

Open in trial search

Obesity+2

Recruiting

A study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S

Obesity+2

Recruiting

A study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Previously Used Biologic Treatments

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:JNJ-77242113
  • Sponsor:Janssen Cilag International

Safety and Pharmacodynamics of RBD4059 and Apixaban in Patients with Non‑Valvular Atrial Fibrillation: A Randomized Active‑Controlled Study

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Ribocure Pharmaceuticals AB

Long‑Term Safety and Efficacy of RO7790121 in Adults with Moderate to Severe Rheumatoid Arthritis: Extension Study

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:RO7790121
  • Sponsor:F. Hoffmann-La Roche AG

Study to evaluate if colchicine reduces inflammation in patients with chronic coronary artery disease

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Rigshospitalet

Cardiac failure+1

Recruiting

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S

Drug dependence

Recruiting

Study of semaglutide to reduce cannabis use in adults with cannabis use disorder

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Region Hovedstaden

A Study of Olpasiran for Patients With Stable Heart and Blood Vessel Disease and High Lipoprotein(a) to Measure Changes in Artery Plaque Using Heart Scans

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Depression

Recruiting

Study of Flumazenil to Reduce Side Effects of Electroconvulsive Therapy in Patients with Depression

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Flumazenil
  • Sponsor:Region Hovedstaden

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Frederiksberg

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking studies focusing on heart failure prevention and innovative treatments for hypertrophic cardiomyopathy. Research includes evaluation of new medications for stroke prevention in patients with atrial fibrillation.

  • Heart Failure Prevention Studies
  • Atrial Fibrillation Management
  • Cardiac Structure Assessment

Novel therapeutic approaches are being tested to reduce cardiovascular events and improve patient outcomes.

02 Rheumatology Studies

Comprehensive research into psoriatic arthritis treatments, including multiple trials testing biological therapies and innovative medications for both biologic-experienced and biologic-naïve patients.

  • Psoriatic Arthritis Treatments
  • Axial Spondyloarthritis Research
  • Inflammatory Disease Management

Studies focus on reducing symptoms and improving quality of life for patients with inflammatory joint conditions.

03 Metabolic Disorders

Advanced research targeting severe hypertriglyceridemia and metabolic conditions. Studies evaluate new therapeutic options and their effectiveness in managing lipid disorders.

  • Lipid Management Therapies
  • Metabolic Disease Treatment
  • Cardiovascular Risk Reduction

Innovative approaches are being investigated to address complex metabolic conditions and their complications.

04 Psychiatric Medicine

Pioneering research examining treatments for alcohol use disorder with concurrent conditions, including studies on innovative therapeutic approaches for patients with schizophrenia.

  • Dual Diagnosis Treatment
  • Addiction Management
  • Mental Health Interventions

Research focuses on developing integrated treatment approaches for complex psychiatric conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.